ICAD Inc.

iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta

Retrieved on: 
Monday, October 23, 2023
Capital Group Companies, FDA, Inc., NMSC, Cancer, Physician, ICAD, CE, Brachytherapy, Brain, Growth, Disease, Skin, ICAD Inc., Gynecologic cancer disparities in the United States, Patient, Prostate, Medical imaging, Elekta

Elekta is taking over the business effective immediately and will make final payment no later than November 6, 2023.

Key Points: 
  • Elekta is taking over the business effective immediately and will make final payment no later than November 6, 2023.
  • By acquiring the Xoft® Axxent® Electronic Brachytherapy (eBx®) System®, Elekta will be able to offer electronic brachytherapy technology to provide expanded access to treatment for a range of cancers.
  • Xoft's unique technology provides targeted cancer care expertly tailored to meet patients’ personalized needs.
  • We are pleased that Elekta will be acquiring the Xoft subsidiary including both the technology and team,” said Dana Brown, President & CEO of iCAD.

iCAD and Google Health Expand Integration of Google’s AI Technology with iCAD’s ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader

Retrieved on: 
Monday, August 14, 2023
ICAD, 3D, ICAD Inc., Woman, Radiology, 2D, Inc., AUC, Cancer, Workload, AI, Google Health, Health, Mammography, Breast cancer, Medical imaging, Medical device

By leveraging the remarkable capabilities of ProFound Detection, iCAD seeks to provide a viable alternative to the current double-reading workflow,” said Dana Brown, President and CEO of iCAD, Inc.

Key Points: 
  • By leveraging the remarkable capabilities of ProFound Detection, iCAD seeks to provide a viable alternative to the current double-reading workflow,” said Dana Brown, President and CEO of iCAD, Inc.
  • “Combining Google’s artificial intelligence (AI) technology with our leading-edge ProFound Breast Health Suite of AI solutions will enhance our technology and expand access to the technology to millions of women and providers worldwide,” added Ms. Brown.
  • But one company can’t make this a reality alone,” said Greg Corrado, Ph.D., Head of Health AI, Google.
  • “With thousands of installations worldwide, our Breast AI solutions are already the most widely used technologies of their kind.

Automated Breast Ultrasound Systems Market was estimated at $1.5 Billion in 2021 and is growing at a CAGR of 14.4% from 2022 to 2032: Market Decipher

Retrieved on: 
Tuesday, December 6, 2022
Statistics, Person, ICAD Inc., Projection, Diagnosis, MRI, Pregnancy, ABUS, Patient, Prevalence, US, Hospital, Radiation exposure, Breast cancer, 3D, Siemens Healthineers, Health Canada, Woman, Obesity, Speed, Government, Investment, Smoking, Numbering Resource Utilization/Forecast Report, Hormone replacement therapy, Traction, Fertility, ICAD, Risk, Medical imaging, Medical device, Hologic

PUNE, India, Dec. 6, 2022 /PRNewswire/ -- The New Report " Automated Breast Ultrasound Systems Market Size, Statistics, Trend Analysis, and Forecast Report, 20222032" shows insights and data published by Market Decipher.

Key Points: 
  • PUNE, India, Dec. 6, 2022 /PRNewswire/ -- The New Report " Automated Breast Ultrasound Systems Market Size, Statistics, Trend Analysis, and Forecast Report, 20222032" shows insights and data published by Market Decipher.
  • The report estimates theAutomated Breast Ultrasound Systems Market size at US$ 1.71 Billion in 2022 which isexpected to reach US$ 6.37 Billion by the end of 2032.
  • Market Decipher reveals increased initiatives by government and private groups to raise breast cancer awareness, which will raise the demand for Automated Breast Ultrasound Systems around the globe.
  • It provides key statistics on the market status of the Automated Breast Ultrasound Systems manufacturers, highlighting influential leading players, market scope, and key developments.

Automated Breast Ultrasound Systems Market was estimated at $1.5 Billion in 2021 and is growing at a CAGR of 14.4% from 2022 to 2032: Market Decipher

Retrieved on: 
Tuesday, December 6, 2022
Statistics, Person, ICAD Inc., Projection, Diagnosis, MRI, Pregnancy, ABUS, Patient, Prevalence, US, Hospital, Radiation exposure, Breast cancer, 3D, Siemens Healthineers, Health Canada, Woman, Obesity, Speed, Government, Investment, Smoking, Numbering Resource Utilization/Forecast Report, Hormone replacement therapy, Traction, Fertility, ICAD, Risk, Medical imaging, Medical device, Hologic

PUNE, India, Dec. 6, 2022 /PRNewswire/ -- The New Report " Automated Breast Ultrasound Systems Market Size, Statistics, Trend Analysis, and Forecast Report, 20222032" shows insights and data published by Market Decipher.

Key Points: 
  • PUNE, India, Dec. 6, 2022 /PRNewswire/ -- The New Report " Automated Breast Ultrasound Systems Market Size, Statistics, Trend Analysis, and Forecast Report, 20222032" shows insights and data published by Market Decipher.
  • The report estimates theAutomated Breast Ultrasound Systems Market size at US$ 1.71 Billion in 2022 which isexpected to reach US$ 6.37 Billion by the end of 2032.
  • Market Decipher reveals increased initiatives by government and private groups to raise breast cancer awareness, which will raise the demand for Automated Breast Ultrasound Systems around the globe.
  • It provides key statistics on the market status of the Automated Breast Ultrasound Systems manufacturers, highlighting influential leading players, market scope, and key developments.

iCAD to Participate in the 13th Annual Craig-Hallum Alpha Select Conference

Retrieved on: 
Tuesday, November 15, 2022
Donald Duck filmography, COVID-19, Disclosure, Conference, Acceleration, Sheraton New York Times Square Hotel, Patient, ICAD Inc., Regulation, Profound Pharma, Security (finance), ICAD, News, Pharmaceutical industry, Medicare

NASHUA, N.H., Nov. 15, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, Chief Executive Officer, will participate at the 13th Annual Craig-Hallum Alpha Select Conference on Thursday, November 17th.

Key Points: 
  • NASHUA, N.H., Nov. 15, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, Chief Executive Officer, will participate at the 13th Annual Craig-Hallum Alpha Select Conference on Thursday, November 17th.
  • The conference will be held at the Sheraton New York Times Square in New York City.
  • Management is scheduled to host one-on-one meetings with investors and attendees during the conference.
  • Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions.

Global Mammography Market Report 2022: A $4.67 Billion Market by 2030 - Size, Share & Trends Analysis - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 17, 2022
Health, General Health, FDA, National Breast Cancer Foundation, Ageing, Canadian National Breast Screening Study, Non-governmental organization, Siemens Healthineers, ICAD, Software, ICAD Inc., Digital, Y-ME National Breast Cancer Organization, Mammography, CDC, U.S. FDA, USD, USFDA, Woman, National Breast Cancer Foundation (United States), DBT, Artificial intelligence, Film screening, Profound Pharma, Growth, CAD, Organization, Tomosynthesis, Diagnosis, Medical imaging, Medical device, Hospital

The "Mammography Market Size, Share & Trends Analysis Report by Product (Film Screen, Digital), by Technology (Breast Tomosynthesis, CAD, Digital), by End-use (Specialty Clinics, Hospitals), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Mammography Market Size, Share & Trends Analysis Report by Product (Film Screen, Digital), by Technology (Breast Tomosynthesis, CAD, Digital), by End-use (Specialty Clinics, Hospitals), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • For instance, the National Breast Cancer Screening Programme in the Netherlands, for example, was created for women aged 50 to 75.
  • According to the program, women in this age bracket were invited for a mammogram every two years.
  • Furthermore, the use of Artificial Intelligence (AI) in 3D mammography has reduced exam time while maintaining image quality.

Ferrum Health to Offer iCAD's Breast AI Technologies within its Women's Health AI Hub

Retrieved on: 
Thursday, November 24, 2022
Radiology, ICAD, Algorithm, DBT, ICAD Inc., Entrepreneurship, Breast cancer, Mammography, Breast, Woman, Tomosynthesis, 3D, Social impact of profound hearing loss, Health, Calcification, AI, Ferrum, Cancer, Neurology, Medical imaging, Medical device

SUNNYVALE, Calif., Nov. 23, 2022 /PRNewswire/ -- Ferrum Health, a leader in healthcare enterprise AI solutions, announces an agreement with iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, to offer iCAD's breast AI solutions on Ferrum Health's platform. The onboarding of iCAD's Profound AI® for Digital Breast Tomosynthesis (DBT) and PowerLook® Density Assessment tools expands Ferrum's suite of AI algorithms within its Women's Health AI Hub.

Key Points: 
  • The onboarding of iCAD's Profound AI for Digital Breast Tomosynthesis (DBT) and PowerLook Density Assessment tools expands Ferrum's suite of AI algorithms within its Women's Health AI Hub.
  • "iCAD's breast AI solutions are playing a significant role in the rapid evolution of breast cancer screening," stated Pelu Tran , CEO and Co-Founder of Ferrum Health.
  • Ferrum Health simplifies the selection, validation, and deployment of healthcare AI with a secure and scalable enterprise AI platform.
  • Ferrum Health developed an enterprise AI deployment platform to improve patient outcomes by democratizing health systems' access to the most innovative and impactful clinical AI technologies worldwide.

Software as a Medical Device Market to Surpass US$ 5.4 Billion by 2032 as Integration of Internet of Things in Healthcare Sector Surges

Retrieved on: 
Tuesday, October 25, 2022
Adoption, Physician, IOT, ICAD Inc., Queen's University, Government, Personal computer, Growth, ICAD, Diagnosis, CAGR, Health, Character, MRI, Artificial intelligence, Technology, University, NEW, Software, Chronic condition, US, Internet, Disease management, Projection, FDA, Solution, Magnetic resonance imaging, Risk management, Medical device, Swoop

NEW YORK, Oct. 25, 2022 /PRNewswire/ -- The global software as a medical device (SaMD) market is expected to reach US$ 1.1 billion in 2022, registering 16.7% CAGR during the forecast period (2022-2032). Sales in the market are projected to surpass US$ 5.4 billion by 2032 as integration of artificial intelligence, and advanced technology is surging in healthcare sector.

Key Points: 
  • Sales in the market are projected to surpass US$ 5.4 billion by 2032 as integration of artificial intelligence, and advanced technology is surging in healthcare sector.
  • Increasing use of Internet of things (IoT) in the healthcare industry and government efforts to improve the infrastructure are likely to drive the growth in software as a medical device market.
  • The market for software as a medical device was dominated by PCs and laptops, in terms of device type.
  • Introduction of AI-based software applications and the advancement of technology will drive the growth in software as a medical device market.

Software as a Medical Device Market to Surpass US$ 5.4 Billion by 2032 as Integration of Internet of Things in Healthcare Sector Surges

Retrieved on: 
Tuesday, October 25, 2022
Adoption, Physician, IOT, ICAD Inc., Queen's University, Government, Personal computer, Growth, ICAD, Diagnosis, CAGR, Health, Character, MRI, Artificial intelligence, Technology, University, NEW, Software, Chronic condition, US, Internet, Disease management, Projection, FDA, Solution, Magnetic resonance imaging, Risk management, Medical device, Swoop

NEW YORK, Oct. 25, 2022 /PRNewswire/ -- The global software as a medical device (SaMD) market is expected to reach US$ 1.1 billion in 2022, registering 16.7% CAGR during the forecast period (2022-2032). Sales in the market are projected to surpass US$ 5.4 billion by 2032 as integration of artificial intelligence, and advanced technology is surging in healthcare sector.

Key Points: 
  • Sales in the market are projected to surpass US$ 5.4 billion by 2032 as integration of artificial intelligence, and advanced technology is surging in healthcare sector.
  • Increasing use of Internet of things (IoT) in the healthcare industry and government efforts to improve the infrastructure are likely to drive the growth in software as a medical device market.
  • The market for software as a medical device was dominated by PCs and laptops, in terms of device type.
  • Introduction of AI-based software applications and the advancement of technology will drive the growth in software as a medical device market.

Global Radiation Oncology Market Report (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts

Retrieved on: 
Monday, October 10, 2022
Adoption, Lung, Risk, Head, Efficiency, Radiation, Neck, CAGR, BD (company), Research, Radiation therapy, Investment, Artificial intelligence, Technology, R, ICAD Inc., Company, Industry, Varian Medical Systems, Pain, Thyroid, Breast, Prostate cancer, Overalls, Siemens, Hitachi, COVID-19, Ion Beam Applications, Radio, Sotera Tschetter, Tobacco, Medical imaging, Potash, Elekta, Growth

DUBLIN, Oct. 10, 2022 /PRNewswire/ -- The "Radiation Oncology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 10, 2022 /PRNewswire/ -- The "Radiation Oncology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global radiation oncology market reached a value of US$ 6.97 Billion in 2021.
  • Radiation oncology, also known as radiotherapy, is a cancer treatment that relies on high doses of radiation to kill cancer cells and shrink tumors.
  • What is the structure of the global radiation oncology market and who are the key players?